Microbiology

  1. Structures and distributions of SARS-CoV-2 spike proteins on intact virions

    1. Zunlong Ke
    2. Joaquin Oton
    3. Kun Qu
    4. Mirko Cortese
    5. Vojtech Zila
    6. Lesley McKeane
    7. Takanori Nakane
    8. Jasenko Zivanov
    9. Christopher J. Neufeldt
    10. Berati Cerikan
    11. John M. Lu
    12. Julia Peukes
    13. Xiaoli Xiong
    14. Hans-Georg Kräusslich
    15. Sjors H. W. Scheres
    16. Ralf Bartenschlager
    17. John A. G. Briggs

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans

    1. Xia Xue
    2. Jianxiang Shi
    3. Hongen Xu
    4. Yaping Qin
    5. Zengguang Yang
    6. Shuaisheng Feng
    7. Danhua Liu
    8. Liguo Jian
    9. Linlin Hua
    10. Yaohe Wang
    11. Qi Zhang
    12. Xueyong Huang
    13. Xiaoju Zhang
    14. Xinxin Li
    15. Chunguang Chen
    16. Jiancheng Guo
    17. Wenxue Tang
    18. Jianbo Liu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Saliva sampling is an excellent option to increase the number of SARS CoV2 diagnostic tests in settings with supply shortages

    1. Joaquín Moreno-Contreras
    2. Marco A. Espinoza
    3. Carlos Sandoval-Jaime
    4. Marco A. Cantú-Cuevas
    5. Héctor Barón-Olivares
    6. Oscar D. Ortiz-Orozco
    7. Asunción V. Muñoz-Rangel
    8. Manuel Hernández-de la Cruz
    9. César M. Eroza-Osorio
    10. Carlos F. Arias
    11. Susana López

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Nanotrap ® particles improve detection of SARS-CoV-2 for pooled sample methods, extraction-free saliva methods, and extraction-free transport medium methods

    1. RA Barclay
    2. I Akhrymuk
    3. A Patnaik
    4. V Callahan
    5. C Lehman
    6. P Andersen
    7. R Barbero
    8. S Barksdale
    9. R Dunlap
    10. D Goldfarb
    11. T Jones-Roe
    12. R Kelly
    13. B Kim
    14. S Miao
    15. A Munns
    16. D Munns
    17. S Patel
    18. E Porter
    19. R Ramsey
    20. S Sahoo
    21. O Swahn
    22. J Warsh
    23. K Kehn-Hall
    24. B Lepene

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Using nucleocapsid proteins to investigate the relationship between SARS-CoV-2 and closely related bat and pangolin coronaviruses

    1. Noah Schuster

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Ag nanoparticles-based antimicrobial polycotton fabrics to prevent the transmission and spread of SARS-CoV-2

    1. Guilherme C. Tremiliosi
    2. Luiz Gustavo P. Simoes
    3. Daniel T. Minozzi
    4. Renato I. Santos
    5. Daiane C. B. Vilela
    6. Edison Luiz Durigon
    7. Rafael Rahal Guaragna Machado
    8. Douglas Sales Medina
    9. Lara Kelly Ribeiro
    10. Ieda Lucia Viana Rosa
    11. Marcelo Assis
    12. Juan Andrés
    13. Elson Longo
    14. Lucio H. Freitas-Junior

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication

    1. Gustavo Garcia
    2. Arun Sharma
    3. Arunachalam Ramaiah
    4. Chandani Sen
    5. Arunima Purkayastha
    6. Donald B. Kohn
    7. Mark S. Parcells
    8. Sebastian Beck
    9. Heeyoung Kim
    10. Malina A. Bakowski
    11. Melanie G. Kirkpatrick
    12. Laura Riva
    13. Karen C. Wolff
    14. Brandon Han
    15. Constance Yuen
    16. David Ulmert
    17. Prabhat K. Purbey
    18. Philip Scumpia
    19. Nathan Beutler
    20. Thomas F. Rogers
    21. Arnab K. Chatterjee
    22. Gülsah Gabriel
    23. Ralf Bartenschlager
    24. Brigitte Gomperts
    25. Clive N. Svendsen
    26. Ulrich A.K. Betz
    27. Robert D. Damoiseaux
    28. Vaithilingaraja Arumugaswami

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Comparison of 12 molecular detection assays for SARS-CoV-2

    1. Yasufumi Matsumura
    2. Tsunehiro Shimizu
    3. Taro Noguchi
    4. Satoshi Nakano
    5. Masaki Yamamoto
    6. Miki Nagao

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Phylogenomics reveals viral sources, transmission, and potential superinfection in early-stage COVID-19 patients in Ontario, Canada

    1. Calvin P. Sjaarda
    2. Nazneen Rustom
    3. Gerald A. Evans
    4. David Huang
    5. Santiago Perez-Patrigeon
    6. Melissa L. Hudson
    7. Henry Wong
    8. Zhengxin Sun
    9. T. Hugh Guan
    10. Muhammad Ayub
    11. Claudio N. Soares
    12. Robert I. Colautti
    13. Prameet M. Sheth

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL pro Reporter Assay

    1. Heather M. Froggatt
    2. Brook E. Heaton
    3. Nicholas S. Heaton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 34 of 233 Next